Questions remain over puberty-blockers, as review clears study

BBC

Deborah Cohen,Hannah Barnes

Over the past year, there have been mounting criticisms of a study into the effects of puberty-blocking drugs when used to treat young people with gender dysphoria – including concerns raised by Newsnight.

The study was carried out at the Gender Identity Development Service (Gids) at London’s Tavistock Clinic – England’s only NHS youth gender clinic – and partly led to the clinic lowering the age at which it offers children puberty blockers. The clinic started recruiting young people to the study in 2011.

Puberty blockers are given to young people who are struggling with their gender identity. They work on the brain to stop the rise in sex hormones – oestrogen and testosterone – that accompanies puberty. These are the hormones that lead to changes in the body, such as periods, breasts or voice-breaking. . . [Full text]